‘I nearly died drinking a ginger beer – my school’s EpiPen saved my life’/in /by
Campaigners want businesses to have EpiPens on hand to treat people having dangerous allergic reactions.
‘I nearly died drinking a ginger beer – my school’s EpiPen saved my life’/in /by
Campaigners want businesses to have EpiPens on hand to treat people having dangerous allergic reactions.
Covid inquiry told of trust do-not-resuscitate rule/in /by
Patients' families were “horrified but not surprised” when told the blanket policy had been in place.
Covid inquiry told of trust do-not-resuscitate rule/in /by
Patients' families were “horrified but not surprised” when told the blanket policy had been in place.
Covid inquiry told of trust do-not-resuscitate rule/in /by
Patients' families were “horrified but not surprised” when told the blanket policy had been in place.
Covid inquiry told of trust do-not-resuscitate rule/in /by
Patients' families were “horrified but not surprised” when told the blanket policy had been in place.
Covid inquiry told of trust do-not-resuscitate rule/in /by
Patients' families were “horrified but not surprised” when told the blanket policy had been in place.
Time to fix NHS as long waits continue, experts say/in /by
Government is urged to show commitment to the NHS at the Budget, as experts sound the alarm over missed targets.
UK firm GSK to pay $2.2bn over Zantac cancer claims/in /by
The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.
UK firm GSK to pay $2.2bn over Zantac cancer claims/in /by
The firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.